EP4 siRNA (m) from Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

(1) Prostaglandin E2 receptor EP4 as the common target on cancer cells and macrophages to abolish angiogenesis, lymphangiogenesis, metastasis, and stem-like cell functionsCancer scienceSeptember 1, 2014Majumder M, Xin X, Liu L, Girish GV, Lala PK.stable knockdown of COX-2 with shRNA plasmid (sc-29278-SH) and transient knockdown of EP4 with siRNA (sc-40174), both obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA). The number of spheroids (at least

(2) Targeting COX-2 and EP4 to control tumor growth, angiogenesis, lymphangiogenesis and metastasis to the lungs and lymph nodes in a breast cancer modelLaboratory investigation; a journal of technical methods and pathologyAugust 1, 2012Xin X, Majumder M, Girish GV, Mohindra V, Maruyama T, Lala PK.three to five targetspecific 19–25 nucleotide siRNAs designed to knockdown mouse EP4 gene expression (SC-40174, Santa Cruz Biotechnology, Santa Cruz, CA, USA) and silence select negative control siRNA (Cat. No:

EP4 siRNA (m)